4 Rumors Buzzing Around Wall Street Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Medifast launches Trilivy, replacing its Optavia brand
Mirati Therapeutics (MRTX) seen worth more than double in a buyout
November 23, 2022 12:40 PM ESTAfter surging nearly 16% Tuesday on fresh takeover rumors, Mirati Therapeutics (NASDAQ: MRTX) is adding another 5% Wednesday as Wall Street analysts weigh in on the company's takeover prospects and value.
Mirati is said to be attracting renewed takeover interest from large pharma companies ahead of updates on its drug pipeline, Bloomberg News reported, citing people familiar with the matter. Investors are awaiting updated PD1 + adagrasib combination data at next month's ESMO I/O meeting. However, the report added that... More
Manchester United (MANU) Confirms Process to Explore Strategic Alternatives to Enhance the Club's Growth
November 22, 2022 4:30 PM ESTManchester United plc (NYSE: MANU), one of the most successful and historic sports clubs in the world, announces today that the Companys Board of Directors (the Board) is commencing a process to explore strategic alternatives for the club.
The process is designed to enhance the club's future growth, with the ultimate goal of positioning the club to capitalize on opportunities both on the pitch and commercially.
As part of this process, the Board will consider all strategic... More
